Literature DB >> 12008782

Therapy for recurrent respiratory papillomatosis.

Karen J Auborn1.   

Abstract

Human papillomaviruses types 6 or 11 are aetiological agents of recurrent respiratory papillomatosis, a disease characterized by benign exophytic tumours usually on the vocal cords. Surgery debulks the tumours, but these growths generally recur at regular intervals. Adjunct medical treatments, aimed at containing the virus and growth of tumours, include indole-3-carbinol or its dimer diindolylmethane, interferon, photodynamic therapy and others. Preventive and therapeutic vaccines hold promise for eliminating the virus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12008782

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  10 in total

Review 1.  Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.

Authors:  Sanjeev Banerjee; Dejuan Kong; Zhiwei Wang; Bin Bao; Gilda G Hillman; Fazlul H Sarkar
Journal:  Mutat Res       Date:  2011-06-15       Impact factor: 2.433

2.  Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR.

Authors:  Satyanarayana R Pondugula; Patrick C Flannery; Kodye L Abbott; Elaine S Coleman; Sridhar Mani; Temesgen Samuel; Wen Xie
Journal:  Toxicol Lett       Date:  2014-12-24       Impact factor: 4.372

3.  Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4.

Authors:  David Gagnon; Simon Joubert; Hélène Sénéchal; Amélie Fradet-Turcotte; Sabrina Torre; Jacques Archambault
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

4.  3,3'-Diindolylmethane stimulates murine immune function in vitro and in vivo.

Authors:  Ling Xue; James J Pestka; Maoxiang Li; Gary L Firestone; Leonard F Bjeldanes
Journal:  J Nutr Biochem       Date:  2007-08-17       Impact factor: 6.048

5.  3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status.

Authors:  Omar I Vivar; Chia-Lei Lin; Gary L Firestone; Leonard F Bjeldanes
Journal:  Biochem Pharmacol       Date:  2009-05-09       Impact factor: 5.858

Review 6.  Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders.

Authors:  Philip B Busbee; Michael Rouse; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Nutr Rev       Date:  2013-04-01       Impact factor: 7.110

7.  3,3'-diindolylmethane reduces levels of HIF-1alpha and HIF-1 activity in hypoxic cultured human cancer cells.

Authors:  Jacques E Riby; Gary L Firestone; Leonard F Bjeldanes
Journal:  Biochem Pharmacol       Date:  2008-02-07       Impact factor: 5.858

8.  Selective activation of estrogen receptor-beta target genes by 3,3'-diindolylmethane.

Authors:  Omar I Vivar; Elise F Saunier; Dale C Leitman; Gary L Firestone; Leonard F Bjeldanes
Journal:  Endocrinology       Date:  2010-02-16       Impact factor: 4.736

9.  Recurrent Respiratory Papillomatosis (RRP)-Juvenile Onset.

Authors:  Sara W Dyrstad; Krishna A Rao
Journal:  Clin Med Oncol       Date:  2008-07-18

10.  A DFT Study of the Geometrical, Spectroscopical and Reactivity Properties of Diindolylmethane-Phenylboronic Acid Hybrids.

Authors:  Amira Jalil Fragoso-Medina; René Gerardo Escobedo-González; María Inés Nicolás-Vázquez; Gabriel Arturo Arroyo-Razo; María Olivia Noguez-Córdova; René Miranda-Ruvalcaba
Journal:  Molecules       Date:  2017-10-17       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.